2nd European League Against Rheumatism (EULAR) Course on Health Economics in Rheumatology
TBDPrague, CZECH REPUBLIC Visit the Venue to read more
Health economics covers an important and increasing part of the assessment of burden of disease. It has become an essential discipline to estimate the benefits and costs of health care interventions, as well as to explore how therapeutic innovations can be made available to physicians and patients in our quite constraint economic environment.
The EULAR Course on Health Economics in Rheumatology aims to present the key principles of health economics applied to rheumatic or musculoskeletal disorders:
Basic principles in health economics and health technology assessment,
Economic burden (Cost-of illness) assessment,
Cost-effectiveness and cost-utility analysis using model- or trial-based data for a better understanding of drug pricing.
The course will be based on interactive learning and practical training.
The participant profile for this two-day course is the following:
Young scientists working in the field of RMDs
Rheumatologists new to the field of health economics and with little experience in this area
Rheumatologists with the intention to involve in a health economics project in the near future
Patient Research Partner representatives
Young researchers attending this course will also have an opportunity to get together for future collaboration. This course will be selective, with competitive admission (send in your CV and motivation text with your online registration). The number of attendees is limited to 30.
2nd European League Against Rheumatism (EULAR) Course on Health Economics in Rheumatology is organized by European League Against Rheumatism (EULAR) and will be held during Apr 05 - 06, 2018 at Prague, Czech Republic. The target audience for this medical event is rheumatologists/trainees/scientists with a confirmed interest in health economics.
To achieve this goal, participants will reach the following specific objectives:
• To understand the principles of the economic analysis in health service research area, with application to musculoskeletal disorders, and to understand drug pricing.
• To describe the economic burden of a disease (cost of illness), and understand all the costs components and their determinants
• To identify the costs and resources involved in a medical intervention
• To assess the cost-effectiveness and cost-utility of a medical intervention using model- or trial-based data
Pr Annelies BOONEN, Maastricht University, Netherlands
• Maarten de WIT, Vrije Universiteit Amsterdam, Netherlands
• Pr Bruno FAUTREL, Sorbonne Universités, France
• Pr Francis GUILLEMIN, Université de Lorraine, France
• Pr Manuela JOORE, Maastricht University, Netherlands
If you have already created an account for another EULAR Congress or course, please enter your details in the appropriate section; Existing users. If you have forgotten your information, please contact us: email@example.com.
If it is the first time you reserve through MCI Suisse SA, please enter your details in the New user section. This account will allow you to manage your reservation and hotel booking 24/24.
You must complete all steps for your reservation to be accepted. It is not possible to save an incomplete reservation and come back to it later.
Following data for each reservation is mandatory: Full Participant name, Institution/Company, E-mail address, Business address and phone.
First Name, Last Name and Country will appear on the name badge.
You will also be asked to indicate a contact person and number in case of emergency.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Contact No.: +41 44 716 30 30
Contact No.: +41 44 716 30 30